Patients with cerebral infarction can usually take butylphthalide for 20 consecutive days during the acute phase of the attack.
Butanephthalein is used for the treatment of mild and moderate acute ischemic stroke.
According to the drug test, butylphthalide has anti-ischemic effect, which can improve the microcirculation and blood flow in the ischemic area of the brain, increase the number of capillaries in the ischemic area; reduce cerebral edema, reduce the size of cerebral infarction; improve cerebral energy metabolism, reduce the apoptosis of neuronal cells; and inhibit thrombosis and other effects.
According to the instructions of the drug, butylphthalide can be taken for 20 days (one course of treatment) in the acute phase of cerebral infarction as prescribed by the doctor, and whether to continue to take it or not should follow the doctor’s advice.
It should be noted that this drug may affect the liver, kidney function, blood clotting function and other aspects, so should not be used without authorization.
Cerebral infarction patients should go to the hospital as soon as possible, standardized diagnosis and treatment, to avoid delaying the condition.